BioMarin Pharmaceutical

BioMarin Pharmaceutical is a biopharmaceutical company that specializes in developing treatments for rare genetic disorders. Founded in 1997, it focuses on innovative therapies, particularly for conditions like dwarfism, hemophilia, and metabolic disorders. The company is known for its commitment to science and patient care, often working closely with communities affected by these diseases. BioMarin's products aim to improve the quality of life for patients by addressing unmet medical needs where traditional treatments may be lacking. Its research combines advanced biotechnology with a deep understanding of genetic conditions.